Menu

Olivier FRANK

ST MAUR DES FOSSES

En résumé

Mes compétences :
Animal health
Healthcare
Marketing

Entreprises

  • Zoetis - European marketing & Integrated Solution Director

    2015 - maintenant EU Integration Leader for Abbott Animal Health business
    EU marketing Team Leader for Analgesia & Anesthesia franchise + anti-emetic business

  • ZOETIS - Directeur des opérations régionales

    2013 - 2015 Dans le cadre de mon développement et afin de compléter mes compétences managériales, j ai accepter une mission de 15 mois comme directeur regional. J'encadre une équipe de 9 collaborateur dont 8 commerciaux ainsi qu'une vétérinaire technique sur la région Nord ouest. Ce secteur génère chez ZOETIS un CA de 15 millions d'euros pour le business vétérinaire animaux de compagnie.

  • Pfizer Animal Health - European marketing associate director– Paris- France

    Paris 2006 - 2013 European Headquarters / Paris

    In Line Products : responsible for the prevention portfollio

    Strategic & Operational EUAFME Team leader :

    - Small Animal for the vaccine franchise $68M
    Copositioning of 2 overlapping vaccine range following merger with FortDodge (Wyeth)

    - Parasiticides franchise $49M
    Copositioning of 2 overlapping parasiticide range following merger with FortDodge (Wyeth)

    - Animal Diagnostic rapid test devices (ex-synbiotics)


    Recent activities :

    - Key stakeholder in the acquisition of an Diagnostic rapid test devices company (Synbiotics)

    - Sucessfully drive the launch of the first generic from Pfizer Animal Helath

    - Introduce new oncology drug (toceranib phosphate/ targeted therapy)for companion animal

  • Pfizer - EUAfME Marketing Manager – USA- New York

    Paris 2005 - 2006 EUrope Africa Middle East Marketing Manager in the New York Headquarters:

    In Line Products

    Team leader Small Animal for the vaccine franchise.
    9 countries team members – 2005 Vaccine Franchise sales of $42 Mil. sales.
    -Conducted a technical and a marketing review of the European vaccine market in order to develop a short-term strategy to generate growth.
    Proposed short-term technical solutions and product differentiation to maintain a 15-year-old range in a very competitive environment.
    -Worked closely with clinical, New Product Marketing and Regulatory to propose a road map strategy, and increase the internal focus around the vaccine business.
    -Worked with the US vaccine marketing team to develop a common understanding of the global market trends and competitor strategy.

    Launch Products

    - Marketing leader for Slentrol, a new product category for canine obesity.
    -Closely involved in the market research for Slentrol :
    -Veterinary and consumer perception of current treatment options around obesity and uptake of Slentrol
    -Establish internal and external brand positioning and messaging
    -Advertising concept testing and pricing studies.
    -Collaborating with Global Marketing team to develop Europe major markets product forecasting
    -Develop Slentrol marketing platform and collateral materials such as professional advertising, sales aids and PR campaign.

    -Redefined launch strategy for new Rabies vaccines across the region to secure sales.

    - Developed a strategies for a new approach in prevention of canine periodontal disease and increase the success of the launch.

    -French representative in EUAfME Brand Team to prepare the launch of an immunomodulator
    -Coordinated with the French team – forecasting – market intelligence – KOL development

  • Pfizer Sante animale - Product Manager - France / Paris

    2003 - 2005 Small Animal Vaccines - €4 Mil. (22% MS); Parasiticides - €2.3 Mil. (10% MS); Antibiotics - €3 Mil. € (21% MS); Oral Corticosteroids - €0.4 Mil. (13% MS)
    -Developed and implemented marketing plans, and value added tools for veterinary clinics.
    -Repositioned Stronghold resulting in +70 % Vol. and +20 % sales increase in 10 months.
    -Established generic strategy for a leading antibiotic to minimize product erosion.
    -Increased Brand visibility and identity to broaden Pfizer vaccine awareness from 25 % in 2002 to over 57 % in 2005 (Biosat MR).
    -Involved in process development and implementation of sales policy from product-based promotion to disease management utilizing multi-products (McKinsey Company).
    -Business-to-Business activities: sales aids, mailings, promotional contests, web visibility; Trade shows / Exhibit booths, professional symposia.
    -Business-to-Consumer activities: pamphlets, branded sales displays, posters.
    -Conducted market research to reposition Stronghold, increase vaccines brand awareness, and for Synulox generic strategy
    -Managed statistics via monthly reports, redefined new sales categories following the merger with Pharmacia.

  • Pfizer Animal Health - Sales Representative - France / Paris

    Paris 1999 - 2003 298 clients pool / 2001 Pfizer Area TO 850K € - Best companion Salesman 2003
    Portfolio management for 4 product lines (antibiotics, vaccines, NSAIDs, anesthetics)
    Direct sales relationships with customers (via PSS)
    PR activities / Veterinary clinics staff technical training meetings / General practitioners anesthetics training sessions in collaboration with an opinion leader

  • Pfizer Animal Health - Chef de produit junior

    Paris 1999 - 1999 PFIZER Animal Health Laboratory - Junior product manager – 6 months internship -France / Paris

Formations

Réseau

Annuaire des membres :